Literature DB >> 9760019

Expression and processing of recombinant human galactosylceramidase.

S Nagano1, T Yamada, N Shinnoh, H Furuya, T Taniwaki, J Kira.   

Abstract

Stable transformants of CHO cells that overexpress human galactosylceramidase (GALC) were established. The GALC within the cell consisted of 50- and 30-kDa proteins. The active GALC secreted into the culture medium in large amounts consisted of the 80-kDa precursor enzyme. We confirmed that the precursor enzyme was taken up by fibroblasts via the mannose-6-phosphate receptor and processed into the 50- and 30-kDa fragments. Fragmentation was inhibited by the lysosomotropic agents chloroquine and NH4Cl, suggesting that it occurs within the lysosome. GALC mutations identified in globoid cell leukodystrophy suppressed fragmentation. Neither the 50- or 30-kDa fragment expressed had GALC activity, indicative that the entire structure is necessary for enzyme activity and that fragments expressed separately cannot associate to form the active enzyme.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9760019     DOI: 10.1016/s0009-8981(98)00095-3

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  18 in total

Review 1.  Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.

Authors:  Je-Seong Won; Avtar K Singh; Inderjit Singh
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

2.  Sneak peak at galactocerebrosidase, Krabbe disease's lysosomal hydrolase.

Authors:  Raquel L Lieberman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-06       Impact factor: 11.205

Review 3.  Krabbe Disease in the Arab World.

Authors:  Hatem Zayed
Journal:  J Pediatr Genet       Date:  2015-03

4.  Chaperone therapy for Krabbe disease: potential for late-onset GALC mutations.

Authors:  Mohammad Arif Hossain; Katsumi Higaki; Seiji Saito; Kazuki Ohno; Hitoshi Sakuraba; Eiji Nanba; Yoshiyuki Suzuki; Keiichi Ozono; Norio Sakai
Journal:  J Hum Genet       Date:  2015-06-25       Impact factor: 3.172

5.  Missense mutation in mouse GALC mimics human gene defect and offers new insights into Krabbe disease.

Authors:  Gregory B Potter; Marta Santos; Muriel T Davisson; David H Rowitch; Dan L Marks; Ernesto R Bongarzone; Magdalena A Petryniak
Journal:  Hum Mol Genet       Date:  2013-04-24       Impact factor: 6.150

6.  Insights into Krabbe disease from structures of galactocerebrosidase.

Authors:  Janet E Deane; Stephen C Graham; Nee Na Kim; Penelope E Stein; Rosamund McNair; M Begoña Cachón-González; Timothy M Cox; Randy J Read
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-29       Impact factor: 11.205

7.  Molecular characterization of mutations that cause globoid cell leukodystrophy and pharmacological rescue using small molecule chemical chaperones.

Authors:  Wing C Lee; Dongcheul Kang; Ena Causevic; Aimee R Herdt; Elizabeth A Eckman; Christopher B Eckman
Journal:  J Neurosci       Date:  2010-04-21       Impact factor: 6.167

8.  Structural snapshots illustrate the catalytic cycle of β-galactocerebrosidase, the defective enzyme in Krabbe disease.

Authors:  Chris H Hill; Stephen C Graham; Randy J Read; Janet E Deane
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

9.  Glucocerebrosidases catalyze a transgalactosylation reaction that yields a newly-identified brain sterol metabolite, galactosylated cholesterol.

Authors:  Hisako Akiyama; Mitsuko Ide; Yasuko Nagatsuka; Tomoko Sayano; Etsuro Nakanishi; Norihito Uemura; Kohei Yuyama; Yoshiki Yamaguchi; Hiroyuki Kamiguchi; Ryosuke Takahashi; Johannes M F G Aerts; Peter Greimel; Yoshio Hirabayashi
Journal:  J Biol Chem       Date:  2020-03-06       Impact factor: 5.157

10.  Macrophages Expressing GALC Improve Peripheral Krabbe Disease by a Mechanism Independent of Cross-Correction.

Authors:  Nadav I Weinstock; Daesung Shin; Narayan Dhimal; Xinying Hong; Eric E Irons; Nicholas J Silvestri; Chelsey B Reed; Duc Nguyen; Oliver Sampson; Yung-Chih Cheng; Joseph T Y Lau; Ernesto R Bongarzone; Julia Kofler; Maria L Escolar; Michael H Gelb; Lawrence Wrabetz; M Laura Feltri
Journal:  Neuron       Date:  2020-05-05       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.